To assess the long-term safety, tolerability, and efficacy of brexpiprazole in patients with agitation associated with dementia due to Alzheimer's disease (AD).
No takes yet. Share an insight, caveat, or question.
Grossberg et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: